Skip to main content

Peer Review reports

From: Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease

Original Submission
30 May 2017 Submitted Original manuscript
16 Jul 2017 Reviewed Reviewer Report - Parakkal Deepak
17 Jul 2017 Reviewed Reviewer Report - Afsaneh Oskouie
26 Jul 2017 Reviewed Reviewer Report - Peter Adriaensens
25 Aug 2017 Author responded Author comments - jacob bjerrum
Resubmission - Version 2
25 Aug 2017 Submitted Manuscript version 2
10 Sep 2017 Reviewed Reviewer Report - Peter Adriaensens
16 Sep 2017 Reviewed Reviewer Report - Afsaneh Oskouie
21 Sep 2017 Reviewed Reviewer Report - Parakkal Deepak
27 Sep 2017 Author responded Author comments - jacob bjerrum
Resubmission - Version 3
27 Sep 2017 Submitted Manuscript version 3
Publishing
29 Sep 2017 Editorially accepted
16 Oct 2017 Article published 10.1186/s12916-017-0949-7

You can find further information about peer review here.

Back to article page